Cargando…
Nalfurafine reduces neuroinflammation and drives remyelination in models of CNS demyelinating disease
OBJECTIVES: Multiple sclerosis (MS) is a neurodegenerative disease characterised by inflammation and damage to the myelin sheath, resulting in physical and cognitive disability. There is currently no cure for MS, and finding effective treatments to prevent disease progression has been challenging. R...
Autores principales: | Denny, Lisa, Al Abadey, Afnan, Robichon, Katharina, Templeton, Nikki, Prisinzano, Thomas E, Kivell, Bronwyn M, La Flamme, Anne C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811802/ https://www.ncbi.nlm.nih.gov/pubmed/33489124 http://dx.doi.org/10.1002/cti2.1234 |
Ejemplares similares
-
The Salvinorin Analogue, Ethoxymethyl Ether Salvinorin B, Promotes Remyelination in Preclinical Models of Multiple Sclerosis
por: Paton, Kelly F., et al.
Publicado: (2021) -
Clozapine administration enhanced functional recovery after cuprizone demyelination
por: Templeton, Nikki, et al.
Publicado: (2019) -
Clozapine reduces infiltration into the CNS by targeting migration in experimental autoimmune encephalomyelitis
por: Robichon, Katharina, et al.
Publicado: (2020) -
Sex Differences in Kappa Opioid Receptor Agonist Mediated Attenuation of Chemotherapy-Induced Neuropathic Pain in Mice
por: Paton, Kelly F., et al.
Publicado: (2022) -
Tuftsin Combines With Remyelinating Therapy and Improves Outcomes in Models of CNS Demyelinating Disease
por: Thompson, Kaitlyn K., et al.
Publicado: (2018)